Search filters

List of works by Michael B Atkins

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A case of checkpoint inhibitor-induced celiac disease

scientific article published on 05 August 2019

A patient with melanoma that became sensitized to immunotherapy after treatment with a CDK4/6 inhibitor

scientific article published on 09 July 2020

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients

scientific article

Age as a prognostic factor in patients with localized melanoma and regional metastases

scientific article

Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma

scientific article published on 01 December 2020

Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis

scholarly article

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. 2021, , 6109

correction of a scholarly article

Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

scientific article published on 01 July 2020

Defining the critical hurdles in cancer immunotherapy

scientific article published on 14 December 2011

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy

scientific article published on 01 May 2020

Evolving impact of long-term survival results on metastatic melanoma treatment

scientific article published on 01 October 2020

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

scientific article published on 30 November 2015

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

scientific article published on 01 April 2020

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma

scientific article published on 26 June 2012

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

scientific article published on 27 February 2014

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)

scientific article published on 20 April 2022

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.

scientific article published on 17 July 2017

Strategies for improving the management of immune-related adverse events

scientific article published on 01 December 2020

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

scientific article published on 20 December 2019

The state of melanoma: challenges and opportunities

scientific article

What's new in melanoma? Combination!

scientific article

Paulina is supported by:

About Paulina

Help